Clinical Trials in Phoenix

Showing 9061-9080 of 16,646 trials

MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

NCT02952001

This study is a non-interventional, observational extension of the Parent study, CLS1001-301 (NCT02595398). The purpose of this study is to characterize the continued clinical benefit(s) regarding safety and efficacy of suprachoroidally administered CLS-TA, triamcinolone acetonide injectable suspension, for the treatment of macular edema associated with non-infectious uveitis.

UveitisUveitis, PosteriorUveitis, Anterior+2 more

Clearside Biomedical, Inc.33 participantsStarted Dec 2017

Phoenix, Arizona, United States • Mountain View, California, United States • Fort Lauderdale, Florida, United States +13 more locations

COMPLETEDPhase 2< 1 mile

Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

NCT02100969

The purpose of this study is to determine whether Hizentra is a safe and effective treatment for people with myasthenia gravis (MG).

Myasthenia Gravis

Mazen Dimachkie, MD23 participantsStarted May 2015

Phoenix, Arizona, United States • Kansas City, Kansas, United States • Buffalo, New York, United States +2 more locations

MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

Find Trials by Condition in Phoenix

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy

2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

BAX 855 PK-guided Dosing

A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

Registry of Sustained Immunity to COVID-19 Among ESKD Patients

DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

Bupivacaine Effectiveness and Safety in SABER® Trial

Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients

Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL

A Novel Approach to Infantile Spasms

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)